Home › Atopic Dermatitis (Eczema) › Florida › St. Petersburg
Atopic Dermatitis (Eczema) clinical trials in St. Petersburg, FL
5 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, St. Petersburg
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
- GCP Research , Global Clinical Professionals, St. Petersburg
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RecruitingPhase 3
- Global Clinical Professionals (GCP) /ID# 266474, St. Petersburg
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- GCP Research, Global Clinical professionals, St. Petersburg
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RecruitingObservational study
- Galderma Investigational Site 7090, St. Petersburg
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Antonio, TX10 studies
- San Diego, CA10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Huntington Beach, CA8 studies
- Troy, MI8 studies
- Indianapolis, IN7 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Burkitt Lymphoma6 studies
- Ovarian Cancer6 studies
- Type 2 Diabetes5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.